Matsui Connie
- SEC CIK
- 0001236537
In the past year, 1 open-market purchase filing worth $40.0K and no sales.
Current role at each company
- ARTL Artelo Biosciences, Inc.Directoras of Jul 21, 2026
- STRO Sutro Biopharma, Inc.Directoras of Jun 9, 2026
- HALO Halozyme Therapeutics, Inc.Directoras of Dec 3, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $40.0K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$40.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Matsui Connie as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
STRO Sutro Biopharma, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 2025 (view filing) | Oct 15 | 1 day | Matsui ConnieDirector | PPurchase | +50.0K | $0.80 | +$40.0K | New position50.0K after |
ARTL Artelo Biosciences, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 5, 2025 (view filing) | May 1 | 4 days | Matsui ConnieDirector | PPurchaseConvertible Promissory Note | – | – | – | – | DerivativePrice outlier |
HALO Halozyme Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 5, 2021 (view filing) | Nov 5 | Same day | Matsui ConnieDirector | SSale | −32.0K | $40.38 | −$1.29M | −15.0%182.0K after | 2 lots |